deltatrials
Recruiting NCT01039922

SwissNET - a Registry for Neuroendocrine Tumours in Switzerland

SwissNET - a Prospective Registry of Patients With Neuroendocrine Tumours in Switzerland

Sponsor: Cantonal Hospital of St. Gallen

Updated 11 times since 2017 Last updated: Jan 20, 2020 Started: Jan 31, 2008 Primary completion: Jan 31, 2028 Completion: Jan 31, 2028

Listed as NCT01039922, this observational or N/A phase trial focuses on Carcinoid Tumor and Neuroendocrine Tumors and remains actively recruiting participants. Sponsored by Cantonal Hospital of St. Gallen, it has been updated 11 times since 2008, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

11 versions recorded
  1. Sep 2025 — Present [monthly]

    Recruiting

  2. Sep 2024 — Sep 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Jul 2023 — Jul 2024 [monthly]

    Recruiting

  5. Jan 2021 — Jul 2023 [monthly]

    Recruiting

Show 6 earlier versions
  1. Feb 2020 — Jan 2021 [monthly]

    Recruiting

  2. Feb 2019 — Feb 2020 [monthly]

    Recruiting

  3. Jun 2018 — Feb 2019 [monthly]

    Recruiting

  4. Apr 2018 — Jun 2018 [monthly]

    Recruiting

    Phase: NANone

  5. May 2017 — Apr 2018 [monthly]

    Recruiting NA

  6. Jan 2017 — May 2017 [monthly]

    Recruiting NA

    First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cantonal Hospital of St. Gallen
  • Ente Ospedaliero Cantonale, Bellinzona
  • Insel Gruppe AG, University Hospital Bern
  • Kantonsspital Graubuenden
  • Kantonsspital Liestal
  • Luzerner Kantonsspital
  • Spital Limmattal Schlieren
  • Spital STS AG
  • Spitalnetz Bern
  • Triemlispital Zurich
  • University Hospital, Basel, Switzerland
  • University Hospital, Geneva
  • University Hospital, Zürich
  • University of Lausanne Hospitals
  • Waid City Hospital, Zurich
Data source: Insel Gruppe AG, University Hospital Bern

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aarau, Switzerland, Aarberg, Switzerland, Affoltern am Albis, Switzerland, Altdorf, Switzerland, Basel, Switzerland, Bellinzona, Switzerland, Bern, Switzerland, Biel, Switzerland, Bruderholz, Switzerland, Burgdorf, Switzerland and 36 more location s